编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 12:00-12:15 |
Essentials of mIDH Diffuse Glioma: Understanding Specificities, Mechanism & Progression of mIDH Diffuse Gliomas |
Mitchel S. Berger | Medical Center, University of California, San Francisco (UCSF) |
2 | 12:15-12:30 |
Targeting a Key Driver in mIDH Diffuse Gliomas |
Wolfgang Wick | University of Heidelberg Medical Center/German Cancer Research Center |
3 | 12:30-12:42 |
Insights and Findings from Regional Studies |
Xiaohui Ren | Chief Physician at the Department of Neurosurgery, Beijing Tiantan Hospital |
编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 13:00-13:15 |
Long-term progression-free survival of patients with mutant isocitrate dehydrogenase 1 or 2 glioma receiving vorasidenib following surgery: results from a Phase 1 perioperative trial and the Phase 3 INDIGO trial |
Wolfgang Wick | University of Heidelberg Medical Center/German Cancer Research Center |
2 | 13:15-13:30 |
Exploring the Neuron-Glioma-Astrocyte Axis in IDH-Mutant Gliomas: Mechanisms, Therapies, and Insights |
Hai Yan | Institute of Molecular & Cell Biology (IMCB) |
3 | 13:30-13:45 |
The Role of Glioma Stem Cells in Radiation Treatment Failure |
Yifang Ping | Southwest Hospital, Army Medical University |
4 | 13:45-14:00 |
Tumor Treating Fields in Glioblastoma: A Deep Dive into Recent Clinical Breakthroughs |
Xuejun Yang | Beijing Tsinghua Changgung Hospital,Tsinghua University |
5 | 14:00-14:15 |
Intraoperative Assessment of Glioma Using Miniaturized Epi-fluorescence Widefield Microscope: A Prospective Comparative Study of Ex-vivo and In-vivo Applications |
Junxia Zhang | Jiangsu Province Hospital |
6 | 14:15-14:30 |
Total Therapy for Diffuse Midline Gliomas: A Potent Multi-Agent Sequential Treatment Strategy |
Maria Tsoli | University of New South Wales (UNSW), Sydney Australia |
7 | 14:30-14:45 |
Locoregional Bi-specific CAR-T cells targeting CD44 and CD133 in Recurrent Glioblastoma: the results of the First-in-human clinical trial (NCT05577091) |
Wei Zhang | Beijing Tiantan Hospital ,Capital Medical University |
8 | 14:45-15:00 |
A novel nuclear RNA HSD52 scaffolding NONO/SFPQ complex modulates DNA damage repair to facilitate temozolomide resistance |
Jinquan Cai | The Second Affiliated Hospital of Harbin Medical University |
9 | 15:00-15:15 |
MSD Special Session:Diagnosis and Treatment of Rare Glioblastomas:Exploration and Insights |
Ke Sai | Sun Yat-sen University Cancer Center |
10 | 15:15-15:30 |
MSD Special Session:Disscussion & Summarize |
编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 15:30-15:45 |
Advantages of IORT in Intracranial Tumors |
Vairavan Narayanan | University Malaya Medical Centre |
2 | 15:45-16:00 |
Quadratic Phenotypic Optimization Platform (QPOP) analysis of Patient-Derived Organoids (PDOs) in identifying effective chemotherapeutic combinations for the treatment of recurrent High Grade Glioma (HGG) |
Yvonne LE Ang | National University Cancer Institute Singapore |
3 | 16:00-16:15 |
Novel Thalidomide Derivative AST-035A Shows Enhanced Anti-Tumor Efficacy against Glioblastoma as a Molecular Glue |
Kihwan Hwang | Seoul National University Bundang Hospital |
4 | 16:15-16:30 |
Defining a comprehensive multi-omic/spectral plasma extracellular vesicles biomarker signature as a diagnostic liquid biopsy biomarker for glioma patients |
Stephen Robinson | |
5 | 16:30-16:45 |
Advancing Survival of Recurrent Glioblastoma through Enhanced Drug Penetration via Focused Ultrasound-Induced Blood-Brain Barrier Modulation: A Systematic Review of Clinical Trials |
Muhammad Alifian Remifta Putra | Universitas Indonesia/Cipto Mangunkusumo National Hospital |
6 | 16:45-17:00 |
Potential predictors of awake surgery failure for insular glioma |
Shigeki Takada | Kyoto University Graduate School of Medicine |
7 | 17:00-17:15 |
Spatiotemporal proliferation activity mappingin gliomas via AQP4 water-exchange MRI |
Yingchao Liu | Shandong provincial hospital, Shandong First Medical University |
8 | 17:15-17:30 |
Determinants of Poor Prognosis after Surgery for Glioblastoma Multiforme: A Retrospective Study of Causes of Morbidity and Mortality in a Low-Middle Income Context |
Haseeb Mehmood Qadri | Punjab Institute of Neurosciences, Lahore |
9 | 17:30-17:45 |
Discussion & Summarize |